PMID- 36441733
OWN - NLM
STAT- MEDLINE
DCOM- 20221130
LR  - 20221213
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 17
IP  - 11
DP  - 2022
TI  - Integrated Diabetes Self-Management (IDSM) mobile application to improve 
      self-management and glycemic control among patients with Type 2 Diabetes Mellitus 
      (T2DM) in Indonesia: A mixed methods study protocol.
PG  - e0277127
LID - 10.1371/journal.pone.0277127 [doi]
LID - e0277127
AB  - The number of patients with diabetes in Indonesia reach 19,47 million in 2021, 
      mostly is caused by the adoption of sedentary and unhealthy lifestyles. 
      Continuous self-management is important in diabetes care. It requires optimal 
      coordination and communication between patients, families, and health care 
      provider. The use of communication technology could be solution to the problem. 
      This study aims to initiate an android-based mobile apps technology as a tool for 
      patient, family, and healthcare provider to optimize patient with T2DM treatment. 
      This study will be conducted in Public Health Centers (PHCs) in Yogyakarta using 
      an exploratory sequential mixed-methods design which is divided into three 
      phases. The first phase will use qualitative descriptive methods. Patients with 
      T2DM, families, nurses, physicians and Health Social Security Agency officers in 
      Indonesia will be involved in a focus group discussion (FGD) and in-depth 
      interviews to understand their needs in optimizing the treatment. The second 
      phase will be the development of an android-based application on the first phase 
      results. The apps will be usability tested by involving experts (heuristic 
      evaluation) and users (think aloud method) to ensure that the apps really meet 
      targeted user's need. In the third phase, we will collect feedback from user 
      after using this apps for three months. The effectiveness of the apps will be 
      measured by self-management improvement and glycemic control of patients with 
      T2DM. The non-equivalent control group design will be applied using a 
      pre-repeated post-test control group. The result of this study will be an 
      Android-based Application which will be called Integrated Diabetes 
      Self-Management (IDSM) app to optimize the implementation of diabetes 
      self-management which can improve glycemic control of patients with T2DM as one 
      of the indicators of the Indonesian Chronic Disease Management Program at PHCs.
CI  - Copyright: (c) 2022 Prihatin Putri et al. This is an open access article 
      distributed under the terms of the Creative Commons Attribution License, which 
      permits unrestricted use, distribution, and reproduction in any medium, provided 
      the original author and source are credited.
FAU - Prihatin Putri, Dewi Murdiyanti
AU  - Prihatin Putri DM
AUID- ORCID: 0000-0003-1864-3728
AD  - Doctoral Program of Medical and Health Sciences, Faculty of Medicine, Public 
      Health and Nursing Universitas Gadjah Mada, Yogyakarta, Indonesia.
AD  - Associate Degree in Nursing Program, YKY Nursing Academy, Yogyakarta, Indonesia.
FAU - Suhoyo, Yoyo
AU  - Suhoyo Y
AD  - Department of Medical Education and Bioethics, Faculty of Medicine, Public Health 
      and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
FAU - Putri Pertiwi, Ariani Arista
AU  - Putri Pertiwi AA
AUID- ORCID: 0000-0001-6439-2304
AD  - Department of Basic and Emergency Nursing Faculty of Medicine, Public Health and 
      Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
FAU - Effendy, Christantie
AU  - Effendy C
AUID- ORCID: 0000-0002-8823-229X
AD  - Department of Medical-Surgical Nursing, Faculty of Medicine, Public Health and 
      Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20221128
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
SB  - IM
MH  - Humans
MH  - Glycemic Control
MH  - *Self-Management
MH  - *Mobile Applications
MH  - Indonesia
MH  - *Diabetes Mellitus, Type 2/therapy
PMC - PMC9704669
COIS- The authors have declared that no competing interests exist.
EDAT- 2022/11/29 06:00
MHDA- 2022/12/01 06:00
PMCR- 2022/11/28
CRDT- 2022/11/28 13:43
PHST- 2021/11/30 00:00 [received]
PHST- 2022/10/21 00:00 [accepted]
PHST- 2022/11/28 13:43 [entrez]
PHST- 2022/11/29 06:00 [pubmed]
PHST- 2022/12/01 06:00 [medline]
PHST- 2022/11/28 00:00 [pmc-release]
AID - PONE-D-21-37892 [pii]
AID - 10.1371/journal.pone.0277127 [doi]
PST - epublish
SO  - PLoS One. 2022 Nov 28;17(11):e0277127. doi: 10.1371/journal.pone.0277127. 
      eCollection 2022.